IndraLab
Statements
reach
"The heatmap presented in Supplemental Figure 10D displays the cross-correlation between the residues P264, I266, R273, and K274 that coordinate Z22, suggesting that Z22 binding to that specific pocket allosterically affects the conformation of the binding epitope, thus interfering with complex formation.To further understand the inhibitory effects of ST80 and Z22 on the regulation of CD73 stability, we performed a series of experiments to determine the optimal dose and treatment duration for ST80 and Z22 to disrupt the OTUD4/CD73 interaction."
reach
"The data together support a great potential of pharmacological targeting of the proteolytic interaction of OTUD4 and CD73 to mitigate tumor immune evasion and revive antitumor T cell immunity.To validate the spatially correlated expression of OTUD4 and CD73 in tumor cells with immune signaling programs in the tumor microenvironment, we performed spatially indexed transcript profiling (GeoMx digital spatial profiling) of tumor tissue sections from 6 patients with TNBC."
sparser
"Using gene pathway analysis (Kyoto Encyclopedia of Genes and Genomes [KEGG]/Reactome) ( xref ) based on spatial transcriptomes, we found Ubl conjugation, TGF-β receptor activity, and SMAD binding pathways pertaining to CD73 PTM modulation were particularly enriched in OTUD4 lo compared with OTUD4 hi tumor areas, further supporting potential protein interactions between OTUD4 and CD73 in tumor cells."
sparser
"To further validate the generality of the OTUD4/CD73 interaction, a series of immunoprecipitation assays across diverse cancer cell lines, including the nonsmall cell lung cancer cell HCC827, human ovarian cancer cell SKOV3, and human colorectal cancer cell HCT116, consistently showed endogenous interaction between CD73 and OTUD4 ( xref , A–D)."
sparser
"As presented in xref , although CD73 (green) was observed both in membrane and cytosol and OTUD4 (red) was observed both in nucleus and cytosol, the interaction between CD73 and OTUD4, in the cytosol as determined by proximity ligation assay ( xref ), suggested a potential link between OTUD4-guided cytosolic deubiquitylation of CD73 and its subsequent displacement onto the cell membrane."
sparser
"To further confirm if amino acids V300 and I301 on CD73 directly mediate its binding to OTUD4, the results depicted in xref and xref reveal a marked decrease in the interaction between mutant CD73 and OTUD4 when the amino acids V300 and I301 are mutated in both MDA-MB231 and MDA-MB468 cells."
sparser
"As indicated in xref and xref , MDA-MB468-CD73 WT cells had a decrease in IFN-γ production and proliferation capacity of CD8 + T cell population than MDA-MB468 vehicle control cells, and the disruption of the CD73-OTUD4 interaction by mutating the V300/I301 sites restored the IFN-γ production and proliferation capacity of CD8 + T cell population comparable to those of the control vector."
reach
"To further validate the generality of the OTUD4/CD73 interaction, a series of immunoprecipitation assays across diverse cancer cell lines, including the nonsmall cell lung cancer cell HCC827, human ovarian cancer cell SKOV3, and human colorectal cancer cell HCT116, consistently showed endogenous interaction between CD73 and OTUD4 (Supplemental Figure 4, A–D)."
reach
"As presented in Supplemental Figure 4E, although CD73 (green) was observed both in membrane and cytosol and OTUD4 (red) was observed both in nucleus and cytosol, the interaction between CD73 and OTUD4, in the cytosol as determined by proximity ligation assay (Supplemental Figure 4F), suggested a potential link between OTUD4-guided cytosolic deubiquitylation of CD73 and its subsequent displacement onto the cell membrane."
reach
"To comprehensively address the mechanism by which the interplay of TRIM21-mediated ubiquitylation and OTUD4-guided deubiquitylation regulates CD73 proteolysis, we conducted structural modeling of the interaction between CD73, TRIM21, and OTUD4 by integrated use of experimental data and docking simulations followed by experimental validation."
sparser
"These findings indicate a therapeutic value of pharmacologically targeting the proteolytic interaction of OTUD4 and CD73 to overcome the resistance of immune checkpoint inhibitors (e.g., anti-PD-L1 antibodies), especially in high CD73-expressing, immunologically suppressive TNBC."
reach
"These results together suggest that both ST80 and Z22 are potential pharmacological inhibitors that specifically block OTUD4/CD73 interaction to destabilize CD73 protein.To understand the mechanisms by which ST80 and Z22 disrupt the interaction between OTUD4 and CD73, we illustrated in Figure 5F that ST80 binds to a hydrophobic area defined by residues I71, P254, Y289, P307, I308, and L309."